Lewis R. Silverman, MD, is one of the foremost researchers into myelodysplastic syndrome (MDS), and was the Principal Investigator for the clinical trials which led to FDA approval of azacitidine, the first drug approved for this disease. In this Grand Rounds presentation, Dr. Silverman discusses the causes, gene mutations, progression, and treatments of MDS—as well as the most recent developments in research.